Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06633536
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-09
Brief Title:
Real-life Treatment Outcomes of Ravulizumab in PNH
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Real-life Treatment Outcomes of Ravulizumab in Polish Patients With Paroxysmal Nocturnal Hemoglobinuria PNH Prospective and Retrospective Multicenter Non-interventional Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PNH-RECORD
Brief Summary:
The PNH-RECORD study a Polish multicenter observational non-interventional open-label retrospective with prospective follow-up
Detailed Description:
PNH-RECORD study aims to aims to collect data on the patients characteristics and clinical outcomes of ravulizumab administered in the scope of routine clinical practice in PNH
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None